Crossmark

Mid-Term Efficacy of Dupilumab in Children Aged ≥ 36 Months to <12 Years With Atopic Dermatitis: A Case Series

Crossref DOI link: https://doi.org/10.1016/j.ad.2023.04.042

Published Print: 2024-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Melgosa Ramos, F.J.

Díaz Corpas, T.

Martín Jiménez, S.

Mateu Puchades, A.
License Information

Text and Data Mining valid from 2024-06-01

Text and Data Mining valid from 2024-06-01

Version of Record valid from 2024-02-15
More Information

This article is maintained by: Elsevier

Article Title: Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2023.04.042

Content Type: simple-article

Copyright: © 2024 AEDV. Published by Elsevier España, S.L.U.